Basic and Clinical Neuroscience Journal
مجله علوم اعصاب پایه و بالینی
BCN
Medical Sciences
http://bcn.iums.ac.ir
137
journal137
2008-126X
2228-7442
10.32598/bcn
en
jalali
1400
8
1
gregorian
2021
11
1
12
6
online
1
fulltext
en
Clinical Significance of Diffusion-weighted Magnetic Resonance Imaging on Treatment Efficacy in MS Patients With Acute Attacks
Clinical Neuroscience
Clinical Neuroscience
Original
Original
<strong>Introduction:</strong> Despite various imaging methods, the accurate diagnosis of numerous neurodegenerative diseases remains controversial. Using advanced imaging techniques, like diffusion-weighted imaging, can help the early detection of Multiple Sclerosis (MS) and evaluation of the treatment efficacy in these patients.<br>
<strong>Methods: </strong>In total, 24 MS patients with acute attack and 30 healthy subjects were considered in our study. Region of Interest (ROI) was defined for acute and chronic plaques and Normal-Appearing White Matter (NAWM) in the patients’ group. In the normal group, ROI only was mapped in the white matter in the same regions of the patient. All MS patients were receiving Methylprednisolone for 3 to 5 days. The rate of clinical disability in these patients was also evaluated based on the Expanded Disability Status Scale (EDSS) index. Finally evaluate changes of ADC values of plaques and NAWM before and after treatment.<br>
<strong>Results:</strong> The Apparent Diffusion Coefficient (ADC) values of acute plaques, the ADC values of NAWM, the number of enhancement in T1w, and EDSS values suggested a significant difference after treatment compared to before treatment. However, the ADC values of chronic plaques revealed no significant difference after treatment. There was a significant positive correlation between the difference in EDSS values before and after treatment.<br>
<strong>Conclusion:</strong> The study results demonstrated that using diffusion technique and ADC values analysis is a proper non-invasive method for MS diagnosis and evaluating treatment efficacy in these patients.
Multiple Sclerosis, Diffusion Magnetic Resonance Imaging, Demyelinating diseases, Methylprednisolone
729
736
http://bcn.iums.ac.ir/browse.php?a_code=A-10-1560-1&slc_lang=en&sid=1
Faezeh
Asaadi
fa.asadi90@yahoo.com
13700319475328460039281
13700319475328460039281
No
Department of Radiology Technology, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fariborz
Faeghi
f_faeghi@sbmu.ac.ir
13700319475328460039282
13700319475328460039282
Yes
Department of Radiology Technology, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farzad
Ashrafi
farzad.ashrafi@gmail.com
13700319475328460039283
13700319475328460039283
No
Neurology Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Morteza
Sanei Taheri
Saneim@gmail.com
13700319475328460039284
13700319475328460039284
No
Department of Radiology, Shohadaye Tajrish Hospital, Tehran, Iran.